John McDermott contributes to roundtable article with Drug Development & Delivery
During a recent roundtable discussion, Drug Development & Delivery posed this question to life science leaders: Which Trends Will Have the Most Impact on Drug Development in 2023? In response, John McDermott, Vice President of Scientific Consulting at Quotient Sciences, shares the benefits that a single, common service platform can have on drug development.
"The pharmaceutical industry is constantly seeking ways to accelerate the drug development process and shorten timelines to reduce costs and deliver medicines to patients earlier – ‘trends’ which are followed annually in the industry." said Mr. McDermott. "The integration of drug manufacturing and program strategy management works to streamline key stages of drug development and fast-track a molecule from first-in-human to proof-of-concept."
Read the rest of John's response and see more insight from other experts in the Drug Development & Delivery article.